growth-margins, giving them a wide ability to price strategically. the coming years. The low investment needed to build a facility (up to 40x less than current solutions) combined with its unique technology makes Tiamat the ideal partner in production scale-up for promising markets that will soon become enormous such as cellular agriculture or cell & gene therapy.